Respiratory Medicine, Mucolytic and Expectorant

Medicine for the respiratory tract, mucolytic and expectorant.

Fluidizes secretions by fragmentation of acid mucopolysaccharides, thus facilitating expectoration from the decrease of viscosity, also activates expectoration with the consequence of expulsion of phlegm. Its maximum action is observed 2 to 3 days after starting the treatment, manifesting itself with increased expectoration of a less viscous product.
It also activates and promotes the ciliated epithelium helping expectoration.

Agent: Coronavirus, Paramyxovirus, Adenovirus, Pestivirus, Pasteurella multocida, Pasteurella haemolytica, Pasteurella multocida, Avibacterium paragallinarum, Escherichia coli, Bordetella bronchiseptica, Bordetella bronchiseptica, Mycoplasma hyopneumoniae, Mycoplasma gallisepticum, Mycoplasma synoviae, Mycoplasma meleagridis, Mycoplasma bovis.

Microorganism: Virus, Bacteria, Mycoplasma.

Affections: Avian Infectious Bronchitis, Bovine Pneumonia, Cholera, Avian Coryza, Chronic Resorptive Disease, Atrophic Rhinitis of Swine, Porcine Enzootic Pneumonia, Avian Mycoplasmosis, Bovine Pneumonia, Parasitic Pneumonias.

Destination: Animal.

Species: Poultry, Cattle, Swine, Bovine.

– Bromhexine-based mucolytic and expectorant for the respiratory system (Bromhexine hydrochloride: 1%)

Dosage: Poultry: 0.5-1 mL once daily for 5-7 consecutive days; Swine: 2-5 mL once daily for 5-7 consecutive days.

Presentation 1 lt and 5 lts.

Vet Line

Economic practices for disease prevention in intensive animal husbandry.
With the incorporation of the biosecurity concept, Nieser products are indispensable in farms, hatcheries, feed processing plants, transport in general, sanitary barriers, sanitary customs for people, maternity wards, equipment, etc.